Your request to link to rcsb for BDBM50069989

• 4QVY: ycp beta5-a49t-mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QVN: ycp beta5-m45v mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QVM: ycp beta5-m45a mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QVL: ycp in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 5L66: yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib (10.15252/EMBJ.201695222 )
• 4QWU: ycp beta5-c52f mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QW0: ycp beta5-a49t-a50v-double mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QW1: ycp beta5-a50v mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QW3: ycp beta5-c63f mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 6TD5: leishmania tarentolae proteasome 20s subunit complexed with lxe408 and bortezomib (10.1021/ACS.JMEDCHEM.0C00499 )
• 2F16: crystal structure of the yeast 20s proteasome in complex with bortezomib (10.1016/J.STR.2005.11.019 )
• 5D0X: yeast 20s proteasome beta5-t1s mutant in complex with bortezomib (10.1038/NCOMMS10900 )
• 4QVW: ycp beta5-a49s-mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QVV: ycp beta5-a49v mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QVQ: ycp beta5-m45i mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 4QVP: ycp beta5-m45t mutant in complex with bortezomib (10.1016/J.STR.2014.11.019 )
• 5L5F: yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib 23-nov-16 5l5f 1 title (10.15252/EMBJ.201695222 )
• 5L5Z: yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib (10.15252/EMBJ.201695222 )
• 7KRZ: human mitochondrial lonp1 in complex with bortezomib
• 6HWM: structure of thermus thermophilus clpp in complex with bortezomib (10.1126/SCIADV.AAW3818 )
• 6HWD: yeast 20s proteasome beta2-g45a mutant in complex with bortezomib (10.1021/ACS.JMEDCHEM.8B01884 )
• 7LXT: structure of plasmodium falciparum 20s proteasome with bound bortezomib
• 6X27: lon protease proteolytic domain complexed with bortezomib (10.1021/ACS.JMEDCHEM.0C02152 )
• 4YPM: crystal structure of a lona protease domain in complex with bortezomib (10.1016/J.STR.2016.03.003 )
• 5BXN: yeast 20s proteasome beta2-g170a mutant in complex with bortezomib (10.1038/S41598-018-24199-0 )
• 5LF3: human 20s proteasome complex with bortezomib at 2.1 angstrom (10.1126/SCIENCE.AAF8993 )
• 7Q0Y: crystal structure of ctx-m-14 in complex with bortezomib (10.1038/S41598-022-09392-6 )
• 8DVH: crystal structure of atp-dependent lon protease from bacillus subtillis (bslonba) (10.3390/IJMS231911425 )
• 5CZ7: yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis (10.1038/NCOMMS10900 )
• 4FWD: crystal structure of the lon-like protease mtalonc in complex with bortezomib (10.1107/S0907444913008214 )